Krempa David
- SEC CIK
- 0001968254
In the past year, 2 open-market sale filings worth $4.86M and no purchases.
Current role at each company
- ETON Eton Pharmaceuticals, Inc.Chief Business Officeras of Aug 24, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.86M
- 2 filings
- Net
- −$4.86M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Krempa David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 (view filing)5:19 PM ET | Aug 24 | Same day | Krempa DavidChief Business Officer | SSale | −25.0K | $65.07 | −$1.63M | −40.3%37.0K after | |
| May 27, 2026 (view filing) | May 22-27 | 5 days | Krempa DavidChief Business Officer | SSale | −100.0K | $32.30 | −$3.23M | −79.8%25.2K after | 5 lots |
| Jun 16, 2025 (view filing) | Jun 12-16 | 4 days | Krempa DavidChief Business Officer | SSale | −34.0K | $14.83 | −$504.3K | −5.3%612.6K after | 3 lots |